In the month of December, 2025, there were as many as 167 drug samples that were flagged as “not of standard quality” (NSQ) across the country, the Union health ministry said.
In a monthly drug alert issued by the Central Drugs Standard Control Organisation (CDSCO), central drug laboratories found 74 samples manufactured by various firms to be NSQ, while state drug testing laboratories identified 93 samples that failed to meet prescribed quality standards.
While four drug samples from North Zone (Ghaziabad) and one each from FDA Ahmedabad, Bihar and Maharashtra were identified as spurious in December, these were manufactured by unauthorised entities using brand names owned by other companies. The matter is under investigation, and action will be taken as per the law, the statement said.
The list of NSQ and spurious drugs is put up on the CDSCO portal every month as part of routine regulatory surveillance activity, with NSQ identification done when a drug sample fails in one or more specified quality parameters.
Also Read: Pharma partner’s assets worth ₹1-cr seized in codeine probe
“For December 2025, central drugs laboratories have identified 74 drug samples to be not of standard quality and state drugs testing laboratories have identified 93 drug samples as NSQ,” the statement said.
The failure is specific to the drug products of the batch tested by the government laboratory, and it does not warrant any concerns on the other drug products available in the market, it said.
This action of identifying NSQ and spurious medicines is taken regularly in collaboration with state regulators to ensure that these drugs are identified and removed from the market, the ministry said.
Follow us
